title: Medication errors related to product names.
abstract: Confusion arising from product naming practices can result in unauthorized drug and improper dose/quantity errors. Efforts by FDA, drug manufacturers, pharmacists, other health care professionals, and patients can reduce the risk of these errors.
authors.affiliation: Educational Program Initiatives, United States Pharmacopeia (USP) Center for the Advancement of Patient Safety, Rockville, Maryland, USA. jps@usp.org
authors.forename: John P
authors.initials: JP
authors.lastname: Santell
authors.forename: Diane D
authors.initials: DD
authors.lastname: Cousins
mesh_terms: D003221:Confusion; D003657:Decision Making; D004348:Drug Labeling; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control*; D004364:Pharmaceutical Preparations; D014481:United States
chemical_list: D004364:Pharmaceutical Preparations